TABLE 1 Preoperative and operative characteristics
Variable Type of hysteroscopy Type of hysteroscopy p- value
Office (n = 222) OR (n = 355)
Age, years, median (IQR) 76 (70-91) 76 (71-93) 0.241
Indications for hysteroscopy Post-menopausal bleeding, n (%) Abnormal sonographic findings a, n (%) Other indications b, n (%) 69 (31.1) 149 (67.1) 4 (1.8) 167 (47.0) 176 (49.6) 12 (3.4) <0.001 <0.001 0.308
Successful procedure, n (%) 194 (87.4) 342 (96.3) <0.001
Incomplete procedure, n (%) 45 (20.3) 6 (1.7) <0.001
Main findings during procedure Endometrial polyp, n (%) Thickened endometrium, n (%) Atrophic endometrium, n (%) Submucosal leiomyoma, n (%) Adhesions, n (%) Vaginal or cervical polyps, n (%) Cervical stenosis, n (%) 122 (55.0) 16 (7.2) 39 (17.6) 19 (8.6) 16 (7.2) 8 (3.6) 54 (24.3) 191 (53.8) 70 (19.7) 80 (22.5) 27 (7.6) 17 (4.8) 7 (2) 52 (14.6) 0.797 <0.001 0.170 0.752 0.269 0.284 0.004
Main types of intervention Total operative hysteroscopy, n (%)
Hysteroscopic polypectomy, n (%)
Hysteroscopic myomectomy, n (%)
Tissue sampling, n (%)
Removal of IUD, n (%)
134 (60.4) 98 (44.1) 13 (5.8) 33 (14.9) 2 (0.9) 335 (94.4) 190 (53.5) 28 (7.9) 123 (34.6) 4 (1.1) <0.001 0.032 0.355 <0.001 >0.999
Main reasons for failure or incomplete procedure Cervical stenosis, n (%)
Pain or intolerance, n (%)
Large/multiple findings or bleeding, n (%)
Uterine perforation, n (%)
Other failure c, n (%)
24 (10.8) 7 (3.15) 35 (15.8) 1 (0. 5) 6 (2.7) 11 (3.1) 0 (0) 2 (0.6) 2 (0. 6) 4 (1.3) <0.001 0.001 <0.001 0.856 0.158
OR, operative room; IQR, interquartile range a Including 5 mm or more thickened endometrium, suspected endometrial polyp, submucosal leiomyoma, or fluid in uterine cavity. b Retained IUD (n = 1), vaginal secretions (n = 1), metastatic workup (n = 10), vaginal lesions (n = 4). c Blocking cervical mass (n = 5), vaginal stenosis (n = 1), uterine prolapse (n = 1), improper visualization (n = 2), failure to extract material (n = 1). OR, operative room; IQR, interquartile range a Including 5 mm or more thickened endometrium, suspected endometrial polyp, submucosal leiomyoma, or fluid in uterine cavity. b Retained IUD (n = 1), vaginal secretions (n = 1), metastatic workup (n = 10), vaginal lesions (n = 4). c Blocking cervical mass (n = 5), vaginal stenosis (n = 1), uterine prolapse (n = 1), improper visualization (n = 2), failure to extract material (n = 1). OR, operative room; IQR, interquartile range a Including 5 mm or more thickened endometrium, suspected endometrial polyp, submucosal leiomyoma, or fluid in uterine cavity. b Retained IUD (n = 1), vaginal secretions (n = 1), metastatic workup (n = 10), vaginal lesions (n = 4). c Blocking cervical mass (n = 5), vaginal stenosis (n = 1), uterine prolapse (n = 1), improper visualization (n = 2), failure to extract material (n = 1). OR, operative room; IQR, interquartile range a Including 5 mm or more thickened endometrium, suspected endometrial polyp, submucosal leiomyoma, or fluid in uterine cavity. b Retained IUD (n = 1), vaginal secretions (n = 1), metastatic workup (n = 10), vaginal lesions (n = 4). c Blocking cervical mass (n = 5), vaginal stenosis (n = 1), uterine prolapse (n = 1), improper visualization (n = 2), failure to extract material (n = 1).